share_log

This Psychedelics Penny Stock Is Up 55% After Successful Study On Microdosing For Autism

This Psychedelics Penny Stock Is Up 55% After Successful Study On Microdosing For Autism

在成功研究了治疗自闭症的微剂量后,这家迷幻药的便士股票上涨了55%
Benzinga Real-time News ·  2022/02/17 06:40

Nova Mentis Life Science Corp (OTCQB:NMLSF) is a biotechnology company focused on psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders. The stock is currently trading around $.06 a share, up more than 50% from its closing price on Tuesday. 

诺瓦曼蒂斯生命科学公司(场外交易代码:NMLSF)是一家生物技术公司,专注于以裸盖菇素为基础的疗法和神经炎性疾病的补充诊断。该股目前的交易价格在每股0.06美元左右,较周二收盘价上涨逾50%。

Why Is The Stock Up More Than 50%? 

为什么股票上涨了50%以上?

The company announced on Wednesday that it successfully completed a pre-clinical study in Italy. The study tested the efficacy of orally administered microdoses of psilocybin in patients with Autism. 

该公司周三宣布,它在意大利成功完成了一项临床前研究。这项研究测试了口服小剂量裸盖菇素对自闭症患者的疗效。

The stock quickly skyrocketed on the positive news, shooting from about three cents a share to more than six cents a share. 

利好消息传出后,该公司股价迅速飙升,从每股约3美分飙升至每股6美分以上。

What Did The Study Find? 

这项研究发现了什么?

According to the company's press release, the results "exceeded all expectations." The study found that a very low dose of Nova Mentis' proprietary psilocybin improved behavioral and cognitive defects associated with Autism. The study also showed little to no side effects associated with the small doses of Nova Mentis' psilocybin product. 

该公司新闻稿称,业绩“超出所有预期”.研究发现,极低剂量的Nova Mentis专利裸盖菇素可以改善与自闭症相关的行为和认知缺陷。这项研究还显示,小剂量的Nova Mentis的裸盖菇素产品几乎没有副作用。

"I am elated to be able to report to the medical community that at long last we may have opened the door to treatment of ASD (Autism Spectrum Disorder), an unmet medical need, that has a devastating impact on the patient, family and society," said  Marvin S. Hausman MD, chairman of NOVA's Scientific Advisory Board. 

诺瓦公司科学顾问委员会主席马文·S·豪斯曼医学博士说:“我很高兴能够向医学界报告,我们可能终于打开了治疗自闭症谱系障碍(自闭症谱系障碍)的大门,这是一种未得到满足的医疗需求,对患者、家庭和社会都有毁灭性的影响。”

Treatments for ASD are unmet, indeed. Hopefully, through work like Nova Mentis' more drugs and therapeutics will be developed to transform the lives and families of those who may be on the Autism spectrum.  

事实上,自闭症的治疗方法还没有得到满足。希望通过像Nova Mentis这样的工作,开发更多的药物和疗法来改变自闭症患者的生活和家庭。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发